Skip to main content

Home

Working For You

1,471,446
Responses to Constituent Letters, Emails, Calls
200 Million+
Federal Dollars Secured for Constituents
32,931
Constituent Cases Helped
78
Bilirakis Authorized Provisions Have Become Law
Contact Us
Your feedback is very important. Contact me regarding issues that are important to you.
Flag Requests
Request a flag flown over the Capitol.
Agency Help
Get help with a federal agency.
Small Businesses
If your small business is in need of assistance, my office is here for you.
Internships
Apply for an internship with my office.
Tours and Tickets
Get information on tours in Washington, DC.
Rep. Bilirakis

About Gus

First elected in 2006, Congressman Gus Bilirakis proudly serves Florida's 12th District. As a Senior Member of the Energy and Commerce Committee, Congressman Bilirakis chairs the Innovation, Data, and Commerce Subcommittee while also sitting on the Health Subcommittee and the Communications and Technology Subcommittee. His dedicated legislative work has resulted in 75 enacted bills since 2015, earning him recognition as the Most Effective Republican Lawmaker in Florida by Vanderbilt's Center for Effective Lawmaking.


Sign up to receive e-mail updates from me on issues that are important to you.

Latest News

July 24, 2026

Washington, D.C. — This week, the House Energy and Commerce Committee has advanced the Helping Educators Respond to Overdoses (HERO) Act, bipartisan legislation introduced by Representatives Gus Bilirakis (R FL) and Raul Ruiz, M.D.

July 23, 2026

Washington, D.C. – Today, Representatives Gus Bilirakis (R-FL-12), Laurel Lee (R-FL-15), and Valerie Foushee (D-NC-04) introduced the bipartisan Stealth Bot Prohibition Act, legislation to establish transparency standards for automated web crawlers and crack down on deceptive bots that conceal their identity while scraping online content.
 

July 21, 2026

Washington, D.C. – Congressman Gus Bilirakis (FL-12) today announced that the bipartisan, bicameral Combating Illicit Xylazine Act, legislation he co authored to combat the growing threat of illicit xylazine trafficking while protecting its legitimate veterinary use, was unanimously approved by the House Committee on Ene